Amy Elazzouzi, Vice President, Finance at Aura Biosciences, Inc. (AURA), sold 553 shares at $10.74 ($6K) on 2024-10-29, disclosed to the SEC on 2024-10-29.
Open-market sale of $6k AURA by Vice President, Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AURA | SELL | 2025-10-29 | $6K | — | Filing → |
| AURA | SELL | 2025-08-18 | $103K | — | Filing → |
| AURA | SELL | 2025-04-16 | $5K | — | Filing → |